Leverage China and India to Transform the Pharma Industry
Steven Pearlstein’s article – “Not What the Doctor Ordered” – in today’s Washington Post makes some excellent points about the self-imposed ills of the pharma industry. Here are some additional perspectives.
The pharma industry needs to figure out how to speed up its rate of new drug …
+ view more
GETTING CHINA AND INDIA RIGHT – Strategies for Leveraging the World’s Fastest Growing Economies For Global Advantage
There’re only two places to turn for companies seeking growth during today’s global financial crisis: China and India, which despite the recent slowdown, are still the world’s fastest growing economies. But while many companies are expanding in China and India, few are getting it right. Most h…
+ view more
Prospects for a More Democratic China?
Hillary Clinton’s decision to choose East Asia as the destination for her first foreign visit after becoming the U.S. Secretary of State reflects an acute realization that Asia has already replaced Europe as America’s most important partner and competitor. Within Asia, China is the rising giant.…
+ view more
How IBM Gets China and India Right!
Trapped in legacy mindsets, far too many corporate leaders continue to view China and India from the narrow lens of just off-shoring and cost reduction. Instead, they need to treat each of these economies as representing four game-changing realities, all strategically compelling, and all playing out…
+ view more
India’s Satyam Scandal – A Blessing in Disguise?
The unfolding Satyam saga, India’s Enron, has been a watershed event in Indian corporate history. According to the now-under-arrest founder’s own public confession, Satyam (India’s fourth largest IT services company) had inflated its reported revenues by 25 percent, its operating margins by ov…
+ view more